FDA Investigator Ni Aye Khin, MD

Ni Aye Khin, MD has conducted inspections on 12 sites in 4 countries as of 13 May 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
12
Last Inspection Date:
13 May 2019
Investigator Role:
FDA Investigation Participant
Redica ID:
100010406
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland, United States of America, France, Latvia
FDA Investigators that have inspected at least one site in common with Ni Aye Khin, MD:
Alanna L Mussawwir Bias, Alicia M Mozzachio, Allen F Hall, Angela Shepas, Barbara D Wright, Barbara M Frazier, Bei Yu, Diane Cvan Leeuwen, Greg K Keshishyan, Humberto Z Gomez, Iram R Hassan, PhD, Jennifer M Menendez, Joel D Martinez, Kaitlyn T Dang, Lakecha N Lewis, Linda Thai, Marilyn S Babu, Melissa J Garcia, Michelle L Safarik, MSPAS, PA C, RAC, Michelle Safarik, MSPAS, PA C, RAC, Phillip D Kronstein, MD, Teena H Aiken, Terrance L Thomas, Yangmin Ning

Ni Aye Khin, MD's Documents

Publish Date Document Type Title
February, 2016 FDA 483 Response Acadia Pharmaceuticals Inc. - Form 483R, 2016-03-02
October, 2003 FDA 483 Response Dr. Alan Wade - Form 483R, 2003-10-23
May, 2019 FDA 483 Puma Biotechnology, Inc. - Form 483, 2019-05-24
September, 2014 FDA 483 AB Science - Form 483, 2014-09-26
March, 2019 FDA 483 INTRA-CELLULAR THERAPIES INC - Form 483, 2019-03-22
November, 2002 EIR Richard Douyon, MD - EIR, 2002-12-01
September, 2014 EIR Binh Bui-Nguyen, MD - EIR, 2014-09-19
November, 2002 EIR Eisdorfer, Carl - EIR, 2002-12-04
September, 2014 EIR AB Science - EIR, 2014-09-26
February, 2016 EIR Acadia Pharmaceuticals Inc. - EIR, 2016-02-17
February, 2019 FDA 483 Tran-Johnson, Tram K. - Form 483, 2019-02-01
July, 2003 FDA 483 Dr. Valda Sevele/Ainars Judeiks (Center #2) - Form 483, 2003-07-03
October, 2003 EIR Dr. Alan Wade - EIR, 2003-10-23
September, 2014 FDA 483 Binh Bui-Nguyen, MD - Form 483, 2014-09-19
May, 2019 FDA 483 Francesco Muntoni, M.D. - Form 483, 2019-05-03
July, 2003 EIR Dr. Valda Sevele/Ainars Judeiks (Center #2) - EIR, 2003-07-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more